"
Team:BostonU/Chimera
From 2014.igem.org
(Difference between revisions)
| Line 24: | Line 24: | ||
<table width="100%" border="0" cellspacing="15" cellpadding="0"> | <table width="100%" border="0" cellspacing="15" cellpadding="0"> | ||
<tr> | <tr> | ||
| - | + | <th scope="col"><center><h3>Phase I</center></h3> | |
| + | </th> | ||
| + | |||
| + | <th scope="col"><center><h3>Phase II</center></h3> | ||
| + | </th> | ||
| + | |||
| + | <th scope="col"><center><h3>Phase III</center></h3> | ||
| + | </th> | ||
</tr> | </tr> | ||
</table> | </table> | ||
Revision as of 00:45, 1 October 2014
| Synthetic biology research revolves around design-build-test cycles for the production of genetic devices. An effective process often depends on protocol robustness and a thorough understanding of individual genetic components. Currently, limited software integration and part characterization represent significant stymying factors to the growth of the field, particularly as researchers endeavor to construct increasingly complex devices with behavior that is difficult to predict. We seek to strengthen the traditional design-build-test cycle by developing a workflow that utilizes bio-design automation software tools and builds upon a thoroughly characterized library of parts. |
 |
|||
|---|---|---|---|---|
The Chimera three-cycle workflowThe Chimera workflow is intended to facilitate the predictive design of complex genetic regulatory networks through its three-cycle approach characterized by the use of computational tools.
 | ||||
